Medical disclaimer

This site is an educational reference about CJC-1295, a research compound that is not an FDA-approved drug. Nothing here is medical advice, a dosing recommendation, or instruction for reconstitution, injection, or use. CJC-1295 appears on FDA's list of bulk substances whose compounding may present significant safety risks, with identified serious adverse events including increased heart rate. No physician or clinician has reviewed this site's editorial content. The separately labeled commercial care section does not sell CJC-1295; it links to provider review for a different compounded tesamorelin/ipamorelin product. That product is not a substitute for CJC-1295 and is not FDA-approved as a combination. CJC-1295 Co may receive revenue from purchases initiated through that flow. Completing intake or payment does not guarantee a prescription; a licensed provider must determine whether treatment is appropriate. If you are an athlete subject to anti-doping rules, review the current WADA Prohibited List with a qualified professional. If you experience a medical emergency, call emergency services.